Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCB-2019 Booster Vaccine Study in Adults
NCT05188677Phase 3Completed
- Sponsor
- Clover Biopharmaceuticals
- Start
- Jun 2022
- Primary completion
- Jun 2023
- Modality
- Recombinant Proteins and Enzymes, Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of SCB-2019 in coronavirus disease 2019 (COVID-19), sponsored by Clover Biopharmaceuticals. Started Jun 2022; status: completed.
02
Drugs
SCB-2019
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05188677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05188677.